# AZI2

## Overview
AZI2, or 5-azacytidine induced 2, is a gene that encodes a protein involved in critical cellular processes, particularly in immune signaling and bone metabolism. The protein, characterized as an adaptor protein, contains an N-terminal coiled-coil domain and a central TBK1-binding domain, which facilitate its interactions with other proteins such as TANK-binding kinase 1 (TBK1) and I-kappa-B kinase epsilon (IKK-i) (Fukasaka2013Critical). These interactions are essential for the regulation of immune responses, including the differentiation and function of dendritic cells, and play a role in bone homeostasis by modulating osteoclast survival (Fukasaka2013Critical; Maruyama20155Azacytidineinduced). Additionally, AZI2 has been implicated in clinical conditions such as methamphetamine sensitivity and cancer, where its role in immune signaling pathways may influence therapeutic outcomes (Okamoto2020FIP200; Zhou2020Functional).

## Structure
AZI2, also known as 5-azacytidine-induced protein 2, is characterized by specific structural domains that are crucial for its function. The protein includes an N-terminal coiled-coil domain and a central TBK1-binding domain, which are essential for its role in immune signaling pathways (Fukasaka2013Critical). The coiled-coil domain facilitates protein-protein interactions, while the TBK1-binding domain is critical for AZI2's interaction with TBK1, a kinase involved in the regulation of immune responses (Fukasaka2013Critical).

The protein's structure allows it to interact with other proteins such as IKK-i and FIP200, indicating its involvement in complex signaling networks (Fukasaka2013Critical; Okamoto2020FIP200). AZI2 is also subject to post-translational modifications, such as phosphorylation, which can regulate its activity and interactions (Okamoto2020FIP200).

While the context does not provide detailed information on the tertiary or quaternary structure of AZI2, its domain architecture suggests a modular design that supports its role as an adaptor protein in immune signaling. The presence of splice variants is suggested, which may alter its functional properties, although specific isoforms are not detailed in the provided context.

## Function
AZI2 (5-azacytidine induced 2) is a gene that encodes a protein involved in regulating bone mass and immune responses. In bone metabolism, AZI2 plays a critical role in fine-tuning osteoclast survival, which is essential for maintaining bone homeostasis. AZI2-deficient mice exhibit increased osteoclast longevity due to enhanced activation of the proto-oncogene tyrosine-protein kinase Src (c-Src), a key factor in osteoclast survival. This increased activation is linked to the regulation of heat shock protein 90 (Hsp90) and its co-chaperone Cdc37, which form a complex with AZI2 to modulate c-Src activity (Maruyama20155Azacytidineinduced).

In the immune system, AZI2 is crucial for the differentiation and function of granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced dendritic cells (GM-DCs). It is necessary for the cell-cycle progression of bone marrow cells in response to GM-CSF, affecting the generation of conventional dendritic cells (cDCs) and their ability to produce cytokines and stimulate T cell activation. AZI2 interacts with TANK-binding kinase 1 (TBK1) to facilitate these processes, highlighting its role in immune cell function and potential applications in dendritic cell therapies (Fukasaka2013Critical).

## Clinical Significance
Mutations and alterations in the expression of the AZI2 gene have been implicated in various clinical conditions. In the context of methamphetamine sensitivity, a study demonstrated that a mutant allele of Azi2 in mice led to an increased locomotor response to methamphetamine, suggesting that changes in AZI2 expression could influence substance use-related traits (Zhou2020Functional; Zhou2021Functional). This indicates a potential role for AZI2 in modulating responses to stimulant drugs, although the exact mechanisms remain unclear.

In cancer, particularly breast cancer, AZI2 is involved in the regulation of immune responses. The interaction between AZI2 and FIP200 affects TBK1 activation, which is crucial for immune checkpoint therapy responses. Disruption of this interaction can enhance the effectiveness of immune checkpoint inhibitors, suggesting that AZI2's role in TBK1 signaling could be targeted to improve cancer immunotherapy outcomes (Okamoto2020FIP200).

AZI2 also plays a critical role in dendritic cell differentiation and function. Its deficiency impairs cytokine production and T cell activation, which are essential for effective immune responses. This highlights the potential impact of AZI2 alterations on immune function and its relevance in immunotherapy (Fukasaka2013Critical).

## Interactions
AZI2, also known as 5-azacytidine induced 2, is involved in several protein interactions that are crucial for its function in immune signaling and bone metabolism. AZI2 contains an N-terminal coiled-coil domain and a central TBK1-binding domain, allowing it to interact with TBK1 (TANK-binding kinase 1) and IKK-i (I-kappa-B kinase epsilon) (Fukasaka2013Critical). These interactions are part of a family of proteins, including TANK and TBKBP1, which also possess coiled-coil domains and TBK1-binding domains (Fukasaka2013Critical). AZI2's interaction with TBK1 is essential for the differentiation of GM-CSF-induced dendritic cells (GM-DCs), as it facilitates the generation of CD11c+ cells and cytokine production in response to TLR ligands (Fukasaka2013Critical).

In the context of bone metabolism, AZI2 interacts with the Hsp90 co-chaperone Cdc37, forming a complex that regulates the activity of proto-oncogene tyrosine-protein kinase Src (c-Src), which is crucial for osteoclast survival. This interaction indirectly inhibits c-Src activity, and its disruption in AZI2-deficient cells leads to excessive osteoclast formation (Maruyama20155Azacytidineinduced). The AZI2-Hsp90-Cdc37 complex is vital for suppressing c-Src activation, thereby influencing bone mass regulation (Maruyama20155Azacytidineinduced).


## References


[1. (Okamoto2020FIP200) Takako Okamoto, Syn Kok Yeo, Mingang Hao, Mary Rose Copley, Michael A. Haas, Song Chen, and Jun-Lin Guan. Fip200 suppresses immune checkpoint therapy responses in breast cancers by limiting azi2/tbk1/irf signaling independent of its canonical autophagy function. Cancer Research, 80(17):3580–3592, September 2020. URL: http://dx.doi.org/10.1158/0008-5472.CAN-20-0519, doi:10.1158/0008-5472.can-20-0519. This article has 26 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.CAN-20-0519)

[2. (Maruyama20155Azacytidineinduced) Kenta Maruyama, Masahiro Fukasaka, Satoshi Uematsu, Osamu Takeuchi, Takeshi Kondo, Tatsuya Saitoh, Mikaël M. Martino, and Shizuo Akira. 5-azacytidine-induced protein 2 (azi2) regulates bone mass by fine-tuning osteoclast survival. Journal of Biological Chemistry, 290(15):9377–9386, April 2015. URL: http://dx.doi.org/10.1074/jbc.M114.631374, doi:10.1074/jbc.m114.631374. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M114.631374)

[3. (Zhou2021Functional) Xinzhu Zhou, Amanda M. Barkley‐Levenson, Patricia Montilla‐Perez, Francesca Telese, and Abraham A. Palmer. Functional validation of a finding from a mouse genome‐wide association study shows that azi2 influences the acute locomotor stimulant response to methamphetamine. Genes, Brain and Behavior, July 2021. URL: http://dx.doi.org/10.1111/gbb.12760, doi:10.1111/gbb.12760. This article has 5 citations.](https://doi.org/10.1111/gbb.12760)

4. (Zhou2020Functional) Functional validation of a finding from a mouse genome-wide association study demonstrates that a mutant allele ofAzi2alters sensitivity to methamphetamine. This article has 0 citations.

[5. (Fukasaka2013Critical) Masahiro Fukasaka, Daisuke Ori, Tatsukata Kawagoe, Satoshi Uematsu, Kenta Maruyama, Toshihiko Okazaki, Tatsuya Kozaki, Tomoko Imamura, Sarang Tartey, Takashi Mino, Takashi Satoh, Shizuo Akira, and Osamu Takeuchi. Critical role of azi2 in gm-csf–induced dendritic cell differentiation. The Journal of Immunology, 190(11):5702–5711, June 2013. URL: http://dx.doi.org/10.4049/jimmunol.1203155, doi:10.4049/jimmunol.1203155. This article has 21 citations.](https://doi.org/10.4049/jimmunol.1203155)